MXPA01008910A - Compuestos de tiazoloindolinona. - Google Patents
Compuestos de tiazoloindolinona.Info
- Publication number
- MXPA01008910A MXPA01008910A MXPA01008910A MXPA01008910A MXPA01008910A MX PA01008910 A MXPA01008910 A MX PA01008910A MX PA01008910 A MXPA01008910 A MX PA01008910A MX PA01008910 A MXPA01008910 A MX PA01008910A MX PA01008910 A MXPA01008910 A MX PA01008910A
- Authority
- MX
- Mexico
- Prior art keywords
- compound
- thiazolindolinone
- thiazolo
- dihydro
- indol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9904930.6A GB9904930D0 (en) | 1999-03-04 | 1999-03-04 | Thiazoloindolinone compounds |
| PCT/US2000/005192 WO2000052013A2 (en) | 1999-03-04 | 2000-03-01 | Thiazoloindolinone compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA01008910A true MXPA01008910A (es) | 2002-03-27 |
Family
ID=10848912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA01008910A MXPA01008910A (es) | 1999-03-04 | 2000-03-01 | Compuestos de tiazoloindolinona. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1159280A2 (xx) |
| JP (1) | JP2003532620A (xx) |
| KR (1) | KR20020005606A (xx) |
| CN (1) | CN1355807A (xx) |
| AU (1) | AU3611000A (xx) |
| BR (1) | BR0008677A (xx) |
| CA (1) | CA2361580A1 (xx) |
| CZ (1) | CZ20013187A3 (xx) |
| GB (1) | GB9904930D0 (xx) |
| HK (1) | HK1041692A1 (xx) |
| HU (1) | HUP0200376A3 (xx) |
| IL (1) | IL144808A0 (xx) |
| MX (1) | MXPA01008910A (xx) |
| NO (1) | NO20014262L (xx) |
| PL (1) | PL351476A1 (xx) |
| TR (1) | TR200102557T2 (xx) |
| WO (1) | WO2000052013A2 (xx) |
| ZA (1) | ZA200106826B (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
| JP2007519757A (ja) * | 2004-12-01 | 2007-07-19 | テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ | ピメクロリマスの調製方法 |
| UA103319C2 (xx) * | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Сполуки бензенсульфонамідтіазолу та -оксазолу$соединения бензенсульфонамидтиазола и -оксазола |
| JP4761000B1 (ja) * | 2010-11-08 | 2011-08-31 | 小野薬品工業株式会社 | 手足症候群の予防および／または治療剤 |
| ES2604705T3 (es) | 2010-03-31 | 2017-03-08 | Ono Pharmaceutical Co., Ltd. | Agente preventivo y/o remedio para el síndrome mano-pie |
| CA3085013A1 (en) | 2017-12-13 | 2019-06-20 | Onquality Pharmaceuticals China Ltd. | A method for preventing or treating egfr-inhibition associated diseases |
| CN114028568A (zh) | 2018-04-16 | 2022-02-11 | 上海岸阔医药科技有限公司 | 预防或治疗肿瘤疗法副作用的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998050356A1 (en) * | 1997-05-07 | 1998-11-12 | Sugen, Inc. | 2-indolinone derivatives as modulators of protein kinase activity |
| GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
-
1999
- 1999-03-04 GB GBGB9904930.6A patent/GB9904930D0/en not_active Ceased
-
2000
- 2000-03-01 KR KR1020017011094A patent/KR20020005606A/ko not_active Application Discontinuation
- 2000-03-01 BR BR0008677-0A patent/BR0008677A/pt not_active Application Discontinuation
- 2000-03-01 CA CA002361580A patent/CA2361580A1/en not_active Abandoned
- 2000-03-01 PL PL00351476A patent/PL351476A1/xx not_active Application Discontinuation
- 2000-03-01 HU HU0200376A patent/HUP0200376A3/hu unknown
- 2000-03-01 EP EP00914762A patent/EP1159280A2/en not_active Withdrawn
- 2000-03-01 CZ CZ20013187A patent/CZ20013187A3/cs unknown
- 2000-03-01 IL IL14480800A patent/IL144808A0/xx unknown
- 2000-03-01 CN CN00804616A patent/CN1355807A/zh active Pending
- 2000-03-01 TR TR2001/02557T patent/TR200102557T2/xx unknown
- 2000-03-01 JP JP2000602239A patent/JP2003532620A/ja active Pending
- 2000-03-01 AU AU36110/00A patent/AU3611000A/en not_active Abandoned
- 2000-03-01 MX MXPA01008910A patent/MXPA01008910A/es not_active Application Discontinuation
- 2000-03-01 WO PCT/US2000/005192 patent/WO2000052013A2/en not_active Application Discontinuation
-
2001
- 2001-08-17 ZA ZA200106826A patent/ZA200106826B/en unknown
- 2001-09-03 NO NO20014262A patent/NO20014262L/no not_active Application Discontinuation
-
2002
- 2002-05-02 HK HK02103309.8A patent/HK1041692A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20013187A3 (cs) | 2002-02-13 |
| WO2000052013A3 (en) | 2000-12-28 |
| CN1355807A (zh) | 2002-06-26 |
| HUP0200376A3 (en) | 2003-07-28 |
| PL351476A1 (en) | 2003-04-22 |
| BR0008677A (pt) | 2002-01-08 |
| IL144808A0 (en) | 2002-06-30 |
| NO20014262D0 (no) | 2001-09-03 |
| NO20014262L (no) | 2001-10-30 |
| HUP0200376A2 (en) | 2002-06-29 |
| TR200102557T2 (tr) | 2007-01-22 |
| KR20020005606A (ko) | 2002-01-17 |
| CA2361580A1 (en) | 2000-09-08 |
| JP2003532620A (ja) | 2003-11-05 |
| AU3611000A (en) | 2000-09-21 |
| HK1041692A1 (zh) | 2002-07-19 |
| GB9904930D0 (en) | 1999-04-28 |
| ZA200106826B (en) | 2003-02-25 |
| EP1159280A2 (en) | 2001-12-05 |
| WO2000052013A2 (en) | 2000-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2199156T3 (es) | Derivados de aza-oxindol sustituidos. | |
| US6818632B2 (en) | 3-(anilinomethylene)oxindoles | |
| US6369086B1 (en) | Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors | |
| US6624171B1 (en) | Substituted aza-oxindole derivatives | |
| US7189716B2 (en) | Tyrosine kinase inhibitors | |
| CN108368089A (zh) | 新化合物 | |
| US6498176B1 (en) | 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors | |
| CZ139097A3 (cs) | 6-Arylpyrido[2,3-d]pyrimidiny a naftyridiny a farmaceutické prostředky na jejich bázi | |
| CZ302486B6 (cs) | N-6-Substituovaný 7-deazapurin, zpusob jeho prípravy a farmaceutická kompozice s jeho obsahem | |
| SK3542002A3 (en) | Pteridinones as kinase inhibitors | |
| PT1246623E (pt) | Compostos específicos para o receptor de adenosina a1,a2a e a3 e as suas utilizações | |
| KR20190104632A (ko) | 트라이사이클릭 자이라제 억제제 | |
| CA2623507C (en) | Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration | |
| JP6797923B2 (ja) | Ａｌｋおよびｓｒｐｋ阻害剤ならびに使用方法 | |
| JP2022517085A (ja) | ハロゲン化アリルアミン系化合物及びその適用 | |
| JP2004508366A (ja) | オキシインドール誘導体 | |
| MXPA01008910A (es) | Compuestos de tiazoloindolinona. | |
| US6492398B1 (en) | Thiazoloindolinone compounds | |
| EP0550566A1 (en) | Antiproliferative substituted naphthalene compounds | |
| KR100723854B1 (ko) | 4,5-아졸로-옥신돌 | |
| JP2003502362A (ja) | 化学療法および／または放射線療法の副作用の苛酷さを防止／軽減するための組成物および方法 | |
| WO2021168341A1 (en) | Solid forms of 1-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-n,n-dimethylmethanamine | |
| CN112079836A (zh) | 三唑并嘧啶类化合物及其盐、组合物和应用 | |
| CA2965813A1 (en) | Spirocyclic containing compounds and pharmaceutical uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |